We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DOYU:NASDAQDouYu International Holdings Limited Analysis

Data as of 2026-06-22 - not real-time

$4.71

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

DouYu’s stock is trading at $4.71, sitting just above the identified support level of $4.42 and below both the 20‑day (≈$4.93) and 50‑day (≈$4.87) simple moving averages, indicating short‑term weakness. The RSI at 45 is neutral, while the MACD shows a bearish divergence (line –0.055 vs signal –0.003), reinforcing downside pressure. Volatility is elevated at over 46% on a 30‑day basis and beta exceeds 1 (≈1.08), suggesting the stock moves more aggressively than the market and has experienced a steep max drawdown of about 51%, which together raise the overall risk profile. Fundamentally, the company trades at a forward PE of ~12.9 versus an industry average of ~16.7, and a price‑to‑book of 0.48, implying a significant valuation discount. Cash reserves exceed $2.2 bn while debt is negligible, but revenue has contracted 13% year‑over‑year and margins remain thin (gross ~14%, operating ~3%). No dividend is paid, so income‑focused investors have little appeal. In summary, the stock is materially undervalued on a pure multiples basis, yet the combination of weak recent price action, high volatility, and slowing top‑line growth tempers enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below short‑term SMAs
  • Bearish MACD histogram
  • Proximity to near‑term support

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Significant valuation discount to peers
  • Strong cash position with minimal debt
  • Potential recovery in Chinese live‑streaming market

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued multiples offering margin of safety
  • Long‑run growth tailwinds in gaming and e‑sports
  • Resilient balance sheet despite current revenue decline

Key Metrics & Analysis

Financial Health

Revenue Growth-13.20%
Profit Margin2.11%
P/E Ratio12.4
ROE3.94%
ROA1.06%
Debt/Equity0.35
P/B Ratio0.5
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI45.0
Support$4.42
Resistance$5.30
MA 20$4.93
MA 50$4.87
MA 200$6.09
MACDBearish
VolumeStable
Fear & Greed Index91.46

Valuation

Target Price$5.97
Upside/Downside26.72%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.08
Volatility46.42%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.